Protein Regulator of Cytokinesis 1 Regulates Autophagy in Hepatitis B Virus‑associated Liver Cancer Development

Overview

Journal Oncol Rep

Specialty Oncology

Date 2025 Feb 11

PMID 39930820

Authors

Jingjing Huang

Xianzhi Cheng

Chuang Wang

Fangyan Gong

Affiliations

Soon will be listed here.

Abstract

Hepatitis B protein x (HBx) is considered a critical contributor to hepatitis B virus (HBV)‑associated liver cancer development. Protein regulator of cytokinesis 1 (PRC1) has been implicated in hepatocarcinogenesis. However, the clinical relevance, biological functions and related regulatory mechanisms of PRC1 in HBV‑associated liver cancer have not yet been clarified. PRC1 expression profiles in liver cancer were obtained from The Cancer Genome Atlas and Gene Expression Profiling Interactive Analysis database and through reverse transcription‑quantitative polymerase chain reaction and immunohistochemistry assays. A series of and assays were used to explore the function of the PRC1 gene and the possible mechanisms through which it affects HBV‑associated liver cancer. PRC1 was overexpressed in HBV‑positive liver cancer tissues. Functional studies demonstrated that HBx induced the expression of the PRC1 gene, which promoted cell autophagy and enhanced viability, invasion and migration. Furthermore, the knockdown of the PRC1 gene or treatment with the autophagosome inhibitor 3‑methyladenine blocked the HBx‑induced autophagic flux, disrupted the formation of autophagosomes, and promoted cell apoptosis. Liver cancer xenograft animal model experiments revealed that inhibition of autophagy by 3‑methyladenine or silencing of the PRC1 gene attenuated HBx‑induced malignant behavior . The absence of autophagy inhibited the expression of Bcl‑2, induced the expression of Bax, and regulated the levels of Th1 and Th2 cytokines. These results elucidate a mechanism wherein the PRC1 gene participates in the occurrence and development of HBV‑associated liver cancer by modulating autophagy. PRC1 could be a potential therapeutic target for liver cancer.

References

Debnath J, Gammoh N, Ryan K . Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023; 24(8):560-575. PMC: 9980873. DOI: 10.1038/s41580-023-00585-z. View

Shi J, Hao S, Liu X, Li Y, Zheng X . Feiyiliu Mixture sensitizes EGFR mutant non-small cell lung cancer to osimertinib by attenuating the PRC1/Wnt/EGFR pathway. Front Pharmacol. 2023; 14:1093017. PMC: 9892466. DOI: 10.3389/fphar.2023.1093017. View

Li Y, Gan L, Lu M, Zhang X, Tong X, Qi D . HBx downregulated decorin and decorin-derived peptides inhibit the proliferation and tumorigenicity of hepatocellular carcinoma cells. FASEB J. 2023; 37(4):e22871. DOI: 10.1096/fj.202200999RR. View

Ajoolabady A, Tang D, Kroemer G, Ren J . Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy. Br J Cancer. 2022; 128(2):190-205. PMC: 9902568. DOI: 10.1038/s41416-022-01998-x. View

Yu J, Li W, Hou G, Sun D, Yang Y, Yuan S . Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Exp Mol Med. 2023; 55(11):2390-2401. PMC: 10689457. DOI: 10.1038/s12276-023-01108-8. View

Shen C, Jiang X, Li M, Luo Y . Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers (Basel). 2023; 15(2). PMC: 9856776. DOI: 10.3390/cancers15020533. View

Li M, Xiao Y, Liu P, Wei L, Zhang T, Xiang Z . 4‑Methoxydalbergione inhibits esophageal carcinoma cell proliferation and migration by inactivating NF‑κB. Oncol Rep. 2023; 49(2). PMC: 9868687. DOI: 10.3892/or.2023.8479. View

Liu Y, Liu X, Luo M, Li Y, Li H . HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells. Discov Med. 2023; 35(179):1035-1042. DOI: 10.24976/Discov.Med.202335179.99. View

Wang Z, Li N, Cai P, Zhang C, Cao G, Yin J . Mechanism of HBx carcinogenesis interaction with non-coding RNA in hepatocellular carcinoma. Front Oncol. 2023; 13:1249198. PMC: 10517716. DOI: 10.3389/fonc.2023.1249198. View

10.

He L, Shen H, Deng H, Zhang X, Xu Y, Shi C . Identification of critical residues in the regulatory protein HBx for Smc5/6 interaction and hepatitis B virus production. Antiviral Res. 2023; 211:105519. DOI: 10.1016/j.antiviral.2022.105519. View

11.

Zhan X, Wu R, Kong X, You Y, He K, Sun X . Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun (Lond). 2022; 43(2):225-245. PMC: 9926958. DOI: 10.1002/cac2.12388. View

12.

Chen W, Chen M, Zhao Z, Weng Q, Song J, Fang S . ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma. Front Mol Biosci. 2020; 7:126. PMC: 7381195. DOI: 10.3389/fmolb.2020.00126. View

13.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

14.

Lei Y, Xu X, Liu H, Chen L, Zhou H, Jiang J . HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G/S cycle. Autophagy. 2021; 17(12):4423-4441. PMC: 8726737. DOI: 10.1080/15548627.2021.1917948. View

15.

Huang J, Zhan Y, Jiang L, Gao Y, Zhao B, Zhang Y . Identification of the Potential Prognosis Biomarkers in Hepatocellular Carcinoma: An Analysis Based on WGCNA and PPI. Int J Gen Med. 2021; 14:9555-9565. PMC: 8670864. DOI: 10.2147/IJGM.S338500. View

16.

Kimkong I, Kunanopparat A . Autophagy related protein 9A increase in hepatitis B virus-associated hepatocellular carcinoma and the role in apoptosis. World J Hepatol. 2021; 12(12):1367-1371. PMC: 7772733. DOI: 10.4254/wjh.v12.i12.1367. View

17.

You H, Zhang N, Yu T, Ma L, Li Q, Wang X . Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis. Br J Cancer. 2023; 128(6):992-1004. PMC: 10006172. DOI: 10.1038/s41416-022-02115-8. View

18.

Yang C, Zhang H, Zhang L, Zhu A, Bernards R, Qin W . Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022; 20(4):203-222. DOI: 10.1038/s41575-022-00704-9. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Gong K, Chen C, Zhan Y, Chen Y, Huang Z, Li W . Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. J Biol Chem. 2012; 287(42):35576-35588. PMC: 3471698. DOI: 10.1074/jbc.M112.370585. View